Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Fidelity National Financial
FNF
$13.9B
| $7.57M | ﹤0.01% |
201,125
+39,686
| +25% | +$1.49M |
|
1927
First Trust Water ETF
FIW
$1.85B
| $7.55M | ﹤0.01% |
95,248
-1,583
| -2% | -$125K |
|
1928
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.09B
| $7.55M | ﹤0.01% |
+266,029
| New | +$7.5M |
|
1929
Amylyx Pharmaceuticals
AMLX
$2.26B
| $7.54M | ﹤0.01% |
204,076
+136,201
| +201% | +$4.83M |
|
1930
Xtrackers S&P 500 ESG ETF
SNPE
$2.63B
| $7.53M | ﹤0.01% |
217,827
+10,188
| +5% | +$354K |
|
1931
Global X Uranium ETF
URA
$5.42B
| $7.53M | ﹤0.01% |
373,820
-51,741
| -12% | -$1.05M |
|
1932
Ironwood Pharmaceuticals
IRWD
$696M
| $7.52M | ﹤0.01% |
607,140
+31,574
| +5% | +$358K |
|
1933
Domo
DOMO
$174M
| $7.51M | ﹤0.01% |
527,510
+2,382
| +0.5% | +$37K |
|
1934
Stellantis
STLA
$21.7B
| $7.49M | ﹤0.01% |
527,449
+202,086
| +62% | +$2.81M |
|
1935
Diamondrock Hospitality Co
DRH
$2.71B
| $7.49M | ﹤0.01% |
914,531
+23,091
| +3% | +$201K |
|
1936
Henry Schein
HSIC
$9.77B
| $7.49M | ﹤0.01% |
93,736
+8,146
| +10% | +$617K |
|
1937
Simulations Plus
SLP
$369M
| $7.49M | ﹤0.01% |
204,697
-5,157
| -2% | -$217K |
|
1938
Idacorp
IDA
$8.27B
| $7.47M | ﹤0.01% |
69,295
-2,544
| -4% | -$264K |
|
1939
Urban Edge Properties
UE
$2.86B
| $7.47M | ﹤0.01% |
530,136
-39,952
| -7% | -$574K |
|
1940
IDEAYA Biosciences
IDYA
$3.42B
| $7.46M | ﹤0.01% |
410,570
+348,005
| +556% | +$5.85M |
|
1941
La-Z-Boy
LZB
$1.58B
| $7.46M | ﹤0.01% |
326,794
-7,092
| -2% | -$172K |
|
|
VRTV
1942
DELISTED
VERITIV CORPORATION
VRTV
| $7.46M | ﹤0.01% |
60,586
+2,858
| +5% | +$346K |
|
|
VIVO
1943
DELISTED
Meridian Bioscience Inc
VIVO
| $7.44M | ﹤0.01% |
224,041
-9,211
| -4% | -$297K |
|
1944
MP Materials
MP
$7.36B
| $7.43M | ﹤0.01% |
305,524
+8,316
| +3% | +$252K |
|
1945
LPL Financial
LPLA
$28.3B
| $7.41M | ﹤0.01% |
34,282
-3,520
| -9% | -$823K |
|
1946
Green Plains
GPRE
$1.18B
| $7.4M | ﹤0.01% |
242,613
-935
| -0.4% | -$28.8K |
|
|
CVSA
1947
Covista Inc
CVSA
$4.25B
| $7.39M | ﹤0.01% |
208,240
-9,079
| -4% | -$354K |
|
1948
WisdomTree India Earnings Fund ETF
EPI
$2.06B
| $7.39M | ﹤0.01% |
226,747
+24,869
| +12% | +$806K |
|
|
FYBR
1949
DELISTED
Frontier Communications
FYBR
| $7.38M | ﹤0.01% |
289,731
+14,015
| +5% | +$337K |
|
1950
Griffon
GFF
$3.95B
| $7.38M | ﹤0.01% |
206,085
-9,501
| -4% | -$317K |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.